During the past decade, Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec" #1 sponsor was "Galera Therapeutics, Inc." with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Montreal Heart Institute" with 2 trials sponsored, "Unity Health Toronto" with 2 trials sponsored and "American Regent, Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec" are "Acute Myocardial Infarction" (1 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Angina Pectoris" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Fibrillation and Flutter" (1 trials). Many other conditions were trialed in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec" in a lesser frequency.

Most popular intervention types in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec" are "Drug" (14 trials), "Biological" (3 trials), "Behavioral" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Cisplatin" (2 trials), "Epacadostat" (2 trials), "Pembrolizumab" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Intégré Universitaire de Santé et de Services Sociaux de la Mauricie-et-du-centre-du-Quebec, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".